Detalles de la búsqueda
1.
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study.
Mem Inst Oswaldo Cruz
; 114: e180517, 2019 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843921
2.
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program.
Mem Inst Oswaldo Cruz
; 109(3): 335-9, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24821058
3.
[For the return of high vaccination coverage]. / Pela reconquista das altas coberturas vacinais.
Cad Saude Publica
; 39(3): e00240022, 2023.
Artículo
en Portugués
| MEDLINE | ID: mdl-37477609
4.
A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.
Front Cardiovasc Med
; 10: 1189320, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37351283
5.
Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response.
Front Public Health
; 10: 1017337, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457326
6.
Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
Front Cell Infect Microbiol
; 11: 656393, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34307188
7.
Vaccine failures: assessing yellow fever, measles, varicella, and mumps vaccines. / Falhas vacinais: avaliando vacinas febre amarela, sarampo, varicela e caxumba.
Cad Saude Publica
; 36Suppl 2(Suppl 2): e00008520, 2020.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-33146313
8.
Surveillance of adverse events following immunization in the late 2010s: an overview of the importance, tools, and challenges. / O panorama da vigilância de eventos adversos pós-vacinação ao fim da década de 2010: importância, ferramentas e desafios.
Cad Saude Publica
; 36Suppl 2(Suppl 2): e00182019, 2020.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-32965327
9.
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.
Front Immunol
; 11: 1382, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32765496
10.
Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.
Arthritis Res Ther
; 21(1): 75, 2019 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871593
11.
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 2433, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31695694
12.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Front Immunol
; 10: 2192, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31616412
13.
Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.
Front Immunol
; 10: 1211, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293563
14.
Pela reconquista das altas coberturas vacinais / For the return of high vaccination coverage / Para la recuperación de altas coberturas de vacunación
Cad. Saúde Pública (Online)
; 39(3): e00240022, 2023. tab, graf
Artículo
en Portugués
|
LILACS-Express
| ID: biblio-1430073
15.
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers.
BMC Pharmacol Toxicol
; 19(1): 1, 2018 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301580
16.
Clinical research for the Brazilian National Immunization Program. / Pesquisa clínica para o Programa Nacional de Imunizações.
Cad Saude Publica
; 36 Suppl 2: e00182719, 2020.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-32876104
17.
Falhas vacinais: avaliando vacinas febre amarela, sarampo, varicela e caxumba / Fallos en vacunas: evaluando vacunas de fiebre amarilla, sarampión, varicela y parotiditis / Vaccine failures: assessing yellow fever, measles, varicella, and mumps vaccines
Cad. Saúde Pública (Online)
; 36(supl.2): e00008520, 2020.
Artículo
en Portugués
| LILACS, SES-SP | ID: biblio-1132881
18.
O panorama da vigilância de eventos adversos pós-vacinação ao fim da década de 2010: importância, ferramentas e desafios / El panorama de la vigilancia de eventos adversos posvacunación al final de la década de 2010: importancia, herramientas y desafíos / Surveillance of adverse events following immunization in the late 2010s: an overview of the importance, tools, and challenges
Cad. Saúde Pública (Online)
; 36(supl.2): e00182019, 2020. graf
Artículo
en Portugués
| LILACS | ID: biblio-1124356
19.
Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study
Mem. Inst. Oswaldo Cruz
; 114: e180517, 2019. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-990193
20.
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
Mem. Inst. Oswaldo Cruz
; 109(3): 335-339, 06/2014. tab
Artículo
en Inglés
| LILACS | ID: lil-711723